This protocol describes a survey undertaken to acquire a snapshot of the distribution of Clostridioides difficile strains in tertiary acute care hospitals in the European Union/European Economic Area (EU/EEA) in 2022–2023
This guidance document includes an updated summary of diagnostic PCR and serology together with detailed information on isolation, culture, identification and epidemiological typing of B. pertussis to help users choose the best methods within the local technical and financial provisions.
This ECDC study protocol describes the technical requirements for implementing future EU-level genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae.
ECDC promotes the performance of external quality assessment (EQA) schemes, in which laboratories are sent simulated clinical specimens or bacterial isolates for testing by routine or reference laboratory methods. EQA schemes, or laboratory proficiency testing, provide information about the accuracy of different characterisation and typing methods as well as antimicrobial susceptibility testing (AST) and the sensitivity of the methods in place to detect a certain pathogen or novel resistance patterns.
This document establishes a protocol for the case detection, laboratory diagnosis and environmental testing of Mycobacterium chimaera infections which are potentially associated with heater-cooler units.
Kick-off meeting and large capacity building workshop of the ERLTB-Net. The meeting was a place for information exchange, networking, analysis of ERLN-TB achievements and planning of future initiatives.
Every other year EU/EEA representatives meet to discuss the specifics of surveillance in the EU/EEA. The aim is to discuss TB epidemiology and progress towards elimination in Europe.
This report sets out the evidence on IGRAs and their use in the diagnosis of latent and active tuberculosis.After reviewing all available evidence, the expert panel concluded that ‘IGRAs should not replace the standard diagnostic methods for diagnosing active TB.’
The ERLTB-Net sub-network of reference laboratories from EU/EEA Member States supports harmonisation of methods and laboratory capacity for tuberculosis diagnosis, antimicrobial susceptibility testing and typing in the EU/EEA.